Structure-based identification of new orally bioavailable BRD9-PROTACs for treating acute myelocytic leukemia.
Zhang J, Duan H, Gui R, Wu M, Shen L, Jin Y, Pang A, Yu X, Zeng S, Zhang B, Lin N, Huang W, Wang Y, Yao X, Li J, Dong X, Zhou Y, Che J.
Zhang J, et al. Among authors: jin y.
Eur J Med Chem. 2023 Oct 17;262:115872. doi: 10.1016/j.ejmech.2023.115872. Online ahead of print.
Eur J Med Chem. 2023.
PMID: 39491427